Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT05655351
Eligibility Criteria:
Inclusion Criteria:
* Candidate for SARS-CoV-2 vaccination with an mRNA vaccine (Pfizer, Moderna).
* Subject has given free and informed consent.
* Subject who has signed the consent form.
* Person affiliated to or beneficiary of a health insurance plan.
Exclusion Criteria:
* Patients under treatment with N-acetylcysteine or sartan.
* Patients with a dysimmune pathology or immunosuppressive treatment.
* Person infected with SARS-CoV-2 within 3 months prior to inclusion.
* Person participating in a category 1 defined RIPH.
* Subject in an exclusion period as determined by another study.
* Person under court protection, guardianship or trusteeship.
* Subject who is unable to give consent.
* Subject for whom it is impossible to give clear information.
* Pregnant or breastfeeding woman.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05655351
Study Brief:
Protocol Section:
NCT05655351